Mark Talary is a successful business developer with a distinguished background in the information technology and services sector. With over a decade of experience in medical devices and biotechnology, he brings expertise in innovation, management, biophysics, and biomedical engineering. Mark began his education studying Maths, Physics & Chemistry at St. Dunstans College, and later pursued a PhD in Biotechnology and Biophysics at Bangor University. His impressive career in both startups and established companies includes CEO and Partner at Assistive Technology GmbH, Partner and CEO at Xonetix AG, and CRO and System Engineering Consultant at Assistive Technology GmbH.

Mark's career highlights include leading Biovotion as VP R&D and later as CTO and Founder. He also directed research at Solianis Monitoring, headed research at Pendragon, was a senior scientist at Aura Biosystems Inc., and worked as a lab-on-a-chip researcher at the University of Wales, Bangor. Mark's vast experience in various positions and organizations demonstrate his leadership abilities, adaptability, and skills, making him an invaluable asset to any organization.